Sidley represented Novo Holdings, a leading international life science investor, on their £50 million investment in Oxford Nanopore Technologies, the leading UK-listed company behind a new generation of molecular sensing technology based on nanopores.
Novo Holdings will invest £50 million in Oxford Nanopore as part of an equity issue and intends to add to this investment over time, with further purchases in the secondary market subject to availability and price (among other factors).
The Sidley team was led by Private Equity partner Robert Darwin, supported by partner James Wood, counsel Ed Perry, and associate Jessica Edwards (M&A and Private Equity).
